COMPASS Pathways plc (FRA:5Y6)
4.600
-0.320 (-6.50%)
At close: Mar 27, 2026
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of €600.93 million as of March 27, 2026. Its market cap has increased by 101.85% in one year.
Market Cap
600.93M
Enterprise Value
501.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.60
Market Cap Chart
Since September 18, 2020, COMPASS Pathways's market cap has increased from 449.43M to 600.93M, an increase of 33.71%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 600.93M | 6.50% |
| Dec 31, 2025 | 564.27M | 125.88% |
| Dec 31, 2024 | 249.81M | -49.02% |
| Dec 29, 2023 | 489.98M | 53.16% |
| Dec 30, 2022 | 319.91M | -60.55% |
| Dec 31, 2021 | 810.94M | -42.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.41B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.20M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 231.13K |
| MagForce AG | 137.58K |